Variant to Function - Translating Genetic Associations into Therapeutic Targets - Opening Remarks

Attend the opening remarks of a scientific symposium focused on translating genetic discoveries into therapeutic applications. Learn about the critical challenge of converting genetic associations into actionable therapeutic targets, biomarkers, and patient stratification assays from Dr. Melina Claussnitzer, Director of the Broad Diabetes Initiative and Associate Director of Scientific Strategy for the Novo Nordisk Foundation Center for Genomic Mechanisms of Disease. Discover how this one-day conference at the Broad Institute brings together researchers to accelerate genetically-informed approaches in healthcare through high-impact science and cross-disciplinary discussions. Gain insights into the symposium's mission to bridge the gap between genetic variant identification and functional understanding, setting the stage for presentations that showcase cutting-edge research in genomic mechanisms of disease and their translation to clinical applications.